Church & Dwight (CHD)Officer bought ~$276K
Michael Read, Officer at Church & Dwight, bought ~$276K of Church & Dwight shares.
- ~$276K
- Approx. value · 3,000 sh @ $92.07
- 5,505
- Holds after · shares reported
- Traded
- May 9, 2025
- Filed
- May 9, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 3, 2025CongressDisclosed purchase of CHD — reported range $1,001 - $15,000
- Mar 10, 2025InsiderOfficer sold ~$6.32M of CHD shares in the open market
- Mar 12, 2025Insider · 1 personInsiders: 2 sales (~$1.2M)
- Mar 24, 2025CongressDisclosed purchase of CHD — reported range $1,001 - $15,000
- Apr 23, 2025CongressDisclosed purchase of CHD — reported range $1,001 - $15,000
- May 5, 2025CongressDisclosed sale of CHD — reported range $1,001 - $15,000
- May 8, 2025InsiderDirector sold ~$1.37M of CHD shares in the open market
- May 9, 2025 · this disclosureInsiderOfficer purchased ~$276K of CHD shares in the open market
What came next
- May 13, 2025Insider · 1 personInsiders: 2 purchases (~$753K)
- May 14, 2025InsiderCEO purchased ~$500K of CHD shares in the open market
- May 14, 2025CongressDisclosed sale of CHD — reported range $15,001 - $50,000
- May 29, 2025InsiderOfficer sold ~$294K of CHD shares in the open market
- May 30, 2025Insider · 2 peopleInsiders: 4 sales (~$2.6M)
- Jun 6, 2025FDARecall: Orajel Baby, Cooling Swabs for Teething, Each Unit 0.007 fl oz (0.22 mL), NET 0.08 FL OZ (2.6 mL) TOTAL, 12 Single-Use Swabs per carton, Manufactured for Churc…
- Jun 6, 2025FDARecall: ZICAM COLD REMEDY MEDICATED NASAL SWABS, 20 Single-Use Swabs per carton, Distributed by Church & Dwight Co,. Inc., Ewing NJ. UPC 7 32216 30120 5
- Jun 6, 2025FDARecall: ZICAM NASAL ALLCLEAR, 20 Single-Use Swabs per carton, Distributed by Church & Dwight Co,. Inc.., Ewing NJ. UPC 7 32216 30165 6
- Jun 16, 2025InsiderOfficer sold ~$627K of CHD shares in the open market
- Jun 17, 2025CongressDisclosed purchase of CHD — reported range $1,001 - $15,000
- Jun 24, 2025CongressDisclosed sale of CHD — reported range $1,001 - $15,000
- Aug 5, 2025InsiderOfficer purchased ~$183K of CHD shares in the open market
- Aug 8, 2025InsiderCFO purchased ~$494K of CHD shares in the open market
- Aug 12, 2025InsiderCEO purchased ~$501K of CHD shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Church & Dwight
For Church & Dwight, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 13 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CHD page.
Other recent filings by Michael Read, EVP, International
- SEC Form 4 at Church & Dwight (CHD)Aug 6, 2025
- SEC Form 4 at Church & Dwight (CHD)Dec 17, 2024
- SEC Form 4 at Church & Dwight (CHD)Dec 17, 2024
- SEC Form 4 at Church & Dwight (CHD)Dec 17, 2024
The full history of Michael Read, EVP, International is on the profile page.
How this filing works
Other disclosures at Church & Dwight
- SEC Form 4Aug 27, 2026
- SEC Form 4Aug 26, 2026
- SEC Form 4Aug 25, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its CHD page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data